149 related articles for article (PubMed ID: 35280940)
21. Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.
MacKay CI; Wong K; Demarest ST; Benke TA; Downs J; Leonard H
Clin Genet; 2021 Jan; 99(1):157-165. PubMed ID: 33047306
[TBL] [Abstract][Full Text] [Related]
22. CDKL5 Deficiency Disorder (CDD)-Rare Presentation in Male.
Rodak M; Jonderko M; Rozwadowska P; Machnikowska-Sokołowska M; Paprocka J
Children (Basel); 2022 Nov; 9(12):. PubMed ID: 36553250
[TBL] [Abstract][Full Text] [Related]
23. Functional and Structural Impairments in the Perirhinal Cortex of a Mouse Model of CDKL5 Deficiency Disorder Are Rescued by a TrkB Agonist.
Ren E; Roncacé V; Trazzi S; Fuchs C; Medici G; Gennaccaro L; Loi M; Galvani G; Ye K; Rimondini R; Aicardi G; Ciani E
Front Cell Neurosci; 2019; 13():169. PubMed ID: 31114483
[TBL] [Abstract][Full Text] [Related]
24. Cortical Visual Impairment in CDKL5 Deficiency Disorder.
Quintiliani M; Ricci D; Petrianni M; Leone S; Orazi L; Amore F; Gambardella ML; Contaldo I; Veredice C; Perulli M; Musto E; Mercuri EM; Battaglia DI
Front Neurol; 2021; 12():805745. PubMed ID: 35153983
[TBL] [Abstract][Full Text] [Related]
25. Age-Related Cognitive and Motor Decline in a Mouse Model of CDKL5 Deficiency Disorder is Associated with Increased Neuronal Senescence and Death.
Gennaccaro L; Fuchs C; Loi M; Pizzo R; Alvente S; Berteotti C; Lupori L; Sagona G; Galvani G; Gurgone A; Raspanti A; Medici G; Tassinari M; Trazzi S; Ren E; Rimondini R; Pizzorusso T; Zoccoli G; Giustetto M; Ciani E
Aging Dis; 2021 Jun; 12(3):764-785. PubMed ID: 34094641
[TBL] [Abstract][Full Text] [Related]
26. Synaptic synthesis, dephosphorylation, and degradation: a novel paradigm for an activity-dependent neuronal control of CDKL5.
La Montanara P; Rusconi L; Locarno A; Forti L; Barbiero I; Tramarin M; Chandola C; Kilstrup-Nielsen C; Landsberger N
J Biol Chem; 2015 Feb; 290(7):4512-27. PubMed ID: 25555910
[TBL] [Abstract][Full Text] [Related]
27. Clinical and functional study of two de novo variations of CDKL5 gene.
You Y; Men X; Wu W; Liu S; He X; Sun S; Wang X; Li B
Neurogenetics; 2023 Oct; 24(4):263-271. PubMed ID: 37584787
[TBL] [Abstract][Full Text] [Related]
28. Novel CDKL5 mutations were found in patients in China: retrospective investigation in cases of CDKL5-related disorders.
Yan Y; He D; Wu J; Hou R; Sun K; Li L
Ital J Pediatr; 2020 Feb; 46(1):27. PubMed ID: 32111237
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive In Silico Functional Prediction Analysis of CDKL5 by Single Amino Acid Substitution in the Catalytic Domain.
Yoshimura Y; Morii A; Fujino Y; Nagase M; Kitano A; Ueno S; Takeuchi K; Yamashita R; Inazu T
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293137
[TBL] [Abstract][Full Text] [Related]
30. Abnormalities of mitochondrial dynamics and bioenergetics in neuronal cells from CDKL5 deficiency disorder.
Van Bergen NJ; Massey S; Stait T; Ellery M; Reljić B; Formosa LE; Quigley A; Dottori M; Thorburn D; Stroud DA; Christodoulou J
Neurobiol Dis; 2021 Jul; 155():105370. PubMed ID: 33905871
[TBL] [Abstract][Full Text] [Related]
31. iPS cells to model CDKL5-related disorders.
Amenduni M; De Filippis R; Cheung AY; Disciglio V; Epistolato MC; Ariani F; Mari F; Mencarelli MA; Hayek Y; Renieri A; Ellis J; Meloni I
Eur J Hum Genet; 2011 Dec; 19(12):1246-55. PubMed ID: 21750574
[TBL] [Abstract][Full Text] [Related]
32. CDKL5 alterations lead to early epileptic encephalopathy in both genders.
Liang JS; Shimojima K; Takayama R; Natsume J; Shichiji M; Hirasawa K; Imai K; Okanishi T; Mizuno S; Okumura A; Sugawara M; Ito T; Ikeda H; Takahashi Y; Oguni H; Imai K; Osawa M; Yamamoto T
Epilepsia; 2011 Oct; 52(10):1835-42. PubMed ID: 21770923
[TBL] [Abstract][Full Text] [Related]
33. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome.
Mari F; Azimonti S; Bertani I; Bolognese F; Colombo E; Caselli R; Scala E; Longo I; Grosso S; Pescucci C; Ariani F; Hayek G; Balestri P; Bergo A; Badaracco G; Zappella M; Broccoli V; Renieri A; Kilstrup-Nielsen C; Landsberger N
Hum Mol Genet; 2005 Jul; 14(14):1935-46. PubMed ID: 15917271
[TBL] [Abstract][Full Text] [Related]
34. CDKL5 deficiency-related neurodevelopmental disorders: a multi-center cohort study in Italy.
Dell'Isola GB; Antonella F; Francesco P; Mario M; Cordelli DM; Piero P; Pasquale P; Alessandro F; Operto FF; Maurizio E; Marco C; Dario P; Sara M; Elisabetta S; Alberto S; Giovanna S; Savasta S; Paolo P; Di Cara G; Fruttini D; Vincenzo S; Pasquale S; Alberto V
J Neurol; 2024 Jun; ():. PubMed ID: 38874638
[TBL] [Abstract][Full Text] [Related]
35. CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders.
Lin C; Franco B; Rosner MR
Hum Mol Genet; 2005 Dec; 14(24):3775-86. PubMed ID: 16330482
[TBL] [Abstract][Full Text] [Related]
36. Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder.
Olson HE; Daniels CI; Haviland I; Swanson LC; Greene CA; Denny AMM; Demarest ST; Pestana-Knight E; Zhang X; Moosa AN; Fidell A; Weisenberg JL; Suter B; Fu C; Neul JL; Percy AK; Marsh ED; Benke TA; Poduri A
J Neurodev Disord; 2021 Sep; 13(1):40. PubMed ID: 34530725
[TBL] [Abstract][Full Text] [Related]
37. Identification of amphiphysin 1 as an endogenous substrate for CDKL5, a protein kinase associated with X-linked neurodevelopmental disorder.
Sekiguchi M; Katayama S; Hatano N; Shigeri Y; Sueyoshi N; Kameshita I
Arch Biochem Biophys; 2013 Jul; 535(2):257-67. PubMed ID: 23651931
[TBL] [Abstract][Full Text] [Related]
38. CDKL5-Related Disorders: From Clinical Description to Molecular Genetics.
Bahi-Buisson N; Bienvenu T
Mol Syndromol; 2012 Apr; 2(3-5):137-152. PubMed ID: 22670135
[TBL] [Abstract][Full Text] [Related]
39. Subcellular distribution of cyclin-dependent kinase-like 5 (CDKL5) is regulated through phosphorylation by dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A).
Oi A; Katayama S; Hatano N; Sugiyama Y; Kameshita I; Sueyoshi N
Biochem Biophys Res Commun; 2017 Jan; 482(2):239-245. PubMed ID: 27840050
[TBL] [Abstract][Full Text] [Related]
40. Vagus nerve stimulation for the treatment of refractory epilepsy in the CDKL5 Deficiency Disorder.
Lim Z; Wong K; Downs J; Bebbington K; Demarest S; Leonard H
Epilepsy Res; 2018 Oct; 146():36-40. PubMed ID: 30071384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
